Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
0,59 %0,67 %17.43x1.98x3.76x10.2x11.22x 67,46 Md
0,62 %0,64 %25.46x3.82x5.22x15.33x19.12x 51,13 Md
-.--%-.--%34.63x6.96x11.76x22.48x26.19x 43,4 Md
3,39 %3,47 %-45.31x2.47x3.19x9.44x11.01x 40,32 Md
-.--%-.--%34.82x1.65x3.61x11.84x13.64x 30,86 Md
-.--%-.--%-7.73x4.69x11.07x-6.8x-6.42x 26,59 Md
-.--%-.--%33.48x3.32x3.12x9.55x11.51x 22,82 Md
-.--%0,05 %61.71x5.7x6.26x43.08x42.21x 19,79 Md
-.--%-.--%25.61x3.6x5.29x14.16x19.53x 16,47 Md
-.--%-.--%-37.83x-6.63x17.69x-53.69x-56.13x 16,29 Md
-.--%-.--%-111.53x12091.1x11.86x-85.1x-118.51x 11,75 Md
0,16 %0,17 %57.91x23.61x35.1x49.64x51.2x 11,35 Md
-.--%-.--%16.81x - 3.58x13.12x15.73x 11,44 Md
-.--%-.--%47.46x - - - - 10,71 Md
2,86 %3,31 %11.72x1.02x1.8x7.26x9.73x 6,15 Md
0,37 %0,43 %28.11x - 7.55x20.02x23.91x 5,73 Md
1,59 %1,76 %14.18x1.3x2.49x6.45x7.82x 5,69 Md
Moyenne 0,56 % 0,62 % 12,17x 867,47x 8,34x 5,44x 5,11x 23,41 Md
Moyenne pondérée par Capi. 0,6 % 0,64 % 13,00x 387,39x 7,19x 8,66x 9,51x
Biopharmacies
🔇